Prolidase activity disregulation in chronic pancreatitis and pancreatic cancer

Hepato-Gastroenterology

Volumn 49, Issue 48, 2002, Pages 1699-1703

  Palka, Jerzy ^a   Surazynski, Arkadiusz ^a   Karna, Ewa ^a   Orlowski, Kazimierz ^a   Puchalski, Zbigniew ^a   Pruzynaski, Krzysztof ^a   Laszkiewicz, Joanna ^a   Dzienis, Henryk ^a  

^a First Department of General Surgery   (Poland)

Author keywords

1 integrin; Chronic pancreatitis; Collagen; Gelatinases; Pancreas; Pancreatic cancer; Prolidase

Indexed keywords

BETA1 INTEGRIN; COLLAGEN; HYDROXYPROLINE; PROLINE DIPEPTIDASE; PROTEIN SUBUNIT;

ARTICLE; CANCER TISSUE; CHRONIC PANCREATITIS; COLLAGEN DEGRADATION; COLLAGEN METABOLISM; CONTROLLED STUDY; DISEASE MARKER; ENZYME ACTIVITY; ENZYME REGULATION; HUMAN; HUMAN TISSUE; PANCREAS CANCER; PANCREAS DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONTENT; PROTEIN EXPRESSION; SAMPLING; WESTERN BLOTTING; ZYMOGRAPHY;

BIOLOGICAL MARKERS; BLOTTING, WESTERN; CHRONIC DISEASE; COLLAGEN; DIPEPTIDASES; HUMANS; INTEGRINS; PANCREATIC NEOPLASMS; PANCREATITIS;

EID: 0036840838     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Gress TM, Menke A, Bachem M, Müller-Pillasch F, Ellenrieder V, Weidenbach H, Wagner M, Adler G: Role of extracellular matrix in pancreatic disease. Digestion 1998; 59:625-637.
2. Kennedy RH, Bockman DE, Uscanga L, Choux R, Grimaud JA, Sarles H: Pancreatic exracellular matrix alteration in chronic pancreatitis. Pancreas 1987; 2:61-72.
3. Gress TM, Müller-Pillasch F, Lerch NM, Friess H, Büchler M, Adler G: Expression and in-situ localization of genes coding for extracellular matrix proteins and extracelular matrix degrading proteases in pancreatic cancer. Int J Cancer 1995; 62:407-413.
4. Klöppel G: Pathology of nonendocrine pancreatic tumors; In: Go VLW EP, DiMagno EP, Gardner JD, Lebenthal E, Reber HA, Scheele GA (Eds.). The Pancreas; Biology, Pathobiology and Disease, Edition 2. New York: Raven Press, 1993; pp. 871-897.
5. Gress TM, Müller-Pillasch F, Lerch NM, Fries H, Büchler M, Beger HG, Adler G: Balance of expression of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in chronic pancreatitis. Z Gastroenterol 1994; 32:221-225.
6. Bornstein P, Sage H: Regulation of collagen gene expression. Prog Nucleic Acid Res Mol Biol 1989; 37:67-106.
7. Hynes RD: Cell surface proteins and malignant transformation. Biochim Biophys Acta 1976; 458:73-107.
8. Slack JL, Parker MI, Robinson VR, Bornstein P: Regulation of collagen I gene expression by ras. Mol Cell Biol 1992; 12:4714-4723.
9. Bissel M: How does extracellular matrix direct gene expression? J Theor Biol 1981; 99:31-68.
10. Carey DJ: Control of growth and differentiation of vascular cells by extracellular matrix. Ann Rev Physiol 1991; 53:161-177.
11. Ruoslahti E: Control of cell motility and tumor invasion by extracellular matrix interaction. Br J Cancer 1992; 66:239-242.
12. Albelda SM, Buck CA: Integrins and other cell adhesion molecules. FASEB J 1990; 4:2868-2880.
13. Bosco M, Chan C, Matsuura N, Takada Y, Zetter BR, Hemler ME: In vitro and in vivo consequences of VLA-2 expression on rhabdomyosarcoma cells. Science 1991; 251:1600-1602.
14. 1 integrins in tumor. Cancer Biol 1963; 4:277-283.
15. Nicolson GL, Poste G: Tumor cell diversity and host responses in cancer metastasis. In: Hickey R (Ed.). Current Problems in Cancer. New York: Year Book Medical Publishers, 1982; pp. 3-83.
16. Bolon I, Gouyer V, Devouassoux M, Vandenbunder B, Wernert N, Moro D, Brambilla C, Brambilla E: Expression of c-ets-1, collagenase 1, and urokinase - type plasminogen activator genes in lung carcinomas. Am J Pathol 1995; 147:1298-1310.
17. Myara I, Charpentier C, Lemonnier A: Prolidase and prolidase deficiency. Life Sci 1984; 34:1985-1998.
18. Yaron A, Naider F: Proline - dependent structual and biological properties of peptides and proteins. Crit Rev Biochem Mol Biol 1993; 28:31-81.
19. Emmerson KS, Phang JM: Hydrolysis of proline dipeptides completely fulfills the proline requirement in a proline-auxotropic Chinese Hamster Ovary cell line. J Nutr 1993; 23:909-914.
20. Jackson SH, Dennis AW, Greenberg M: Iminodipeptiduria: a genetic defect in recycling collagen; a method for determining prolidase in erythrocytes. CMA Journal 1975; 113:759-763.
21. Palka JA, Phang JM: Prolidase activity in fibroblast is regulated by interaction of extracellular matrix with cell surface integrin receptors. J Cell Biochem 1997; 67:166-175.
22. Becker V, Stömmer P: Pathology and classification of tumors of the pancreas. In: Trede M, Carter DC, Longmire WPJr. (Eds). Surgery of the pancreas. Second Edition. Churchill Livingstone, 1997.
23. Ammann RW: Clinically based classification system for alcoholic chronic pancreatitis: summary of an intenational workshop on chronic pancreatitis. Pancreas 1997; 14:215-221.
24. Myara I, Charpentier C, Lemonnier A: Optimal conditions for prolidase essay by proline colorimetric determination: application to imidodipeptiduria. Clin Chim Acta 1982; 125:193-205.
25. Chinard FP: Photometric estimation of proline and ornithine. J Biol Chem 1952; 199:91-95.
26. Laemmli UK: Cleavege of structural protein during the assembly if the head baceriophage T4. Nature (London) 1970; 27:680-685.
27. Unemori EN, Werb Z: Reorganization of polymerized actin: a possible trigger for induction of procollagenase in fibroblasts cultured in and on collagen gels. J Cell Biol 1986; 103:1021-1031.
28. Lowry OH, Rosenbrough NI, Far AL, Randall IR: Protein measurement with the Folin reagent. J Biol Chem 1951; 193:265.
29. Prockop DJ, Udenfriend S: A specific method for the analysis of hydroxyproline in tissues and urine. Anal Biochem 1960; 1:228-239.
30. Brown PD, Bloxide RE, Anderson E, Howell A: Expression of activated gelatinase in human invasive breast carcinoma. Clin Exp Metastasis 1993; 11:183-189.
31. Miltyk W, Karna E, Palka J: Inhibition of prolidase activity by collagen - degradation products. Med Sci Monit 1997; 3:6-12.
32. Löhr M, Trautmann B, Göttler M, Peters S, Zauner I, Klöppel G: Human ductal adenocarcinomas of the pancreas express extracellular matrix proteins. Br J Cancer 1994; 49:144-151.
33. Chen WT: Membrane proteases: Role in tissue remodeling and tumor invasion. Curr Opin Cell Biol 1992; 4:802-809.
34. Sunada H, Nagai Y: Mechanism of collagen degradation by collagenase: A transition process of the collagen molecule from collagenase substrate to gelatinase substrate. Biomed Res 1983: 4:61-69.
35. Nakajima M, Chop AM: Tumor invasion and extracellular matrix degradative enzymes: regulation of activity by organ factors. Cancer Biol 1991; 2:115-127.
36. Chamson A, Voigtlander V, Myara I, Frey J: Collagen biosynthetic anomalies in prolidase deficiency: effect of glycyl-L-proline on the degradation of newly synthesized collagen. Clin Physiol Bioch 1989; 7:128-136.
37. Myara I, Miech G, Fabre M, Mangeot M, Lemonnier A: Changes in prolinase and prolidase activity during CCl4 administration inducing liver cytolysis and fibrosis in rat. Br J Exp Path 1987; 68:7-13.
38. Miltyk W, Karna E, Palka J: Inhibition of prolidase activity by non-steroid antiinflammatory drugs in cultured human skin fibroblasts. Pol J Pharmacol 1996; 48:609-613.
39. Palka J, Miltyk W, Karna E, Wolczynski S: Modulation of prolidase activity during in vivo aging of human skin fibroblasts the role of extracellular matrix collagen. Tokai J Exp Clin Med 1996; 21:207-213.
40. Palka JA, Karna E, Miltyk W: Fibroblast chemotaxis prolidase activity modulation by insulin-like growth factor II and mannose 6-phosphate. Mol Cell Biochem 1997; 168:177-183.